Strides Pharma Science Sustainability Profile
Strides Pharma Science Limited, commonly referred to as Strides, is a prominent player in the global pharmaceutical industry, headquartered in Bengaluru, India. Founded in 1990, the company has established a strong presence in various operational regions, including North America, Europe, and Africa. Strides focuses on the development, manufacturing, and marketing of a diverse range of pharmaceutical products, particularly in the areas of generic medications, complex generics, and over-the-counter (OTC) products. With a commitment to quality and innovation, Strides has achieved significant milestones, including the establishment of state-of-the-art manufacturing facilities and a robust pipeline of products. The company is recognised for its unique offerings in the injectable and oral dosage forms, positioning itself as a trusted partner in the healthcare sector. Strides Pharma Science continues to strengthen its market position through strategic collaborations and a dedication to meeting the evolving needs of patients worldwide.
DitchCarbon Score
How does Strides Pharma Science's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Strides Pharma Science's score of 35 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Strides Pharma Science's reported carbon emissions
In 2025, Strides Pharma Science reported total carbon emissions of approximately 70.3 million kg CO2e, comprising 5.4 million kg CO2e from Scope 1, 17.1 million kg CO2e from Scope 2, and 47.8 million kg CO2e from Scope 3 emissions. The company has set a target to reduce absolute Scope 1 and Scope 2 emissions by 42% by FY2030, using FY2023 as the baseline year. Strides Pharma is also committed to formulating a long-term decarbonisation strategy aimed at contributing to the global Net Zero agenda by 2050, covering both Scope 1 and Scope 2 emissions. The emissions data is sourced directly from Strides Pharma Science Limited, with no cascading from a parent or related organization. The company is actively working towards its climate commitments within the pharmaceuticals, biotechnology, and life sciences sector, demonstrating a proactive approach to sustainability and emissions reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Scope 1 | 6,206,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 19,960,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 00,000,000 | 00,000,000 |
How Carbon Intensive is Strides Pharma Science's Industry?
How Carbon Intensive is Strides Pharma Science's Location?
Strides Pharma Science's Scope 3 Categories Breakdown
Strides Pharma Science's Scope 3 emissions, which increased by 0% last year and increased by approximately 0% since 2024, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 68% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 44% of Scope 3 emissions.
Top Scope 3 Categories
Strides Pharma Science's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Strides Pharma Science has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Strides Pharma Science's sustainability data and climate commitments